Polar Capital Holdings’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-654,258	Closed	-$63.9M	–	270
2025 Q3	$63.9M	Buy	654,258 +200,001	+44%	+$20.7M	0.31%	81
2025 Q2	$48.8M	Sell	454,257 -16,856	-4%	-$1.71M	0.26%	93
2025 Q1	$47.5M	Sell	471,113 -3,567	-0.8%	-$359K	0.29%	98
2024 Q4	$42.4M	Sell	474,680 -71,696	-13%	-$6.31M	0.24%	106
2024 Q3	$45.8M	Sell	546,376 -64,223	-11%	-$5.06M	0.22%	92
2024 Q2	$47M	Sell	610,599 -38,404	-6%	-$2.81M	0.28%	85
2024 Q1	$44.5M	Sell	649,003 -364,102	-36%	-$23.4M	0.23%	94
2023 Q4	$58.6M	Buy	1,013,105 +351,659	+53%	+$18.8M	0.36%	77
2023 Q3	$34.9M	Sell	661,446 -169,647	-20%	-$8.9M	0.26%	101
2023 Q2	$45M	Sell	831,093 -422,848	-34%	-$22.1M	0.31%	92
2023 Q1	$62.7M	Sell	1,253,941 -960,042	-43%	-$45.2M	0.46%	69
2022 Q4	$102M	Buy	2,213,983 +13,682	+0.6%	+$592K	0.82%	28
2022 Q3	$85.2K	Sell	2,200,301 -10,967	-0.5%	-$440K	0.54%	44
2022 Q2	$82.4K	Buy	2,211,268 +55,000	+3%	+$2.24M	0.48%	49
2022 Q1	$95.5K	Buy	2,156,268 +29,209	+1%	+$1.27M	0.44%	50
2021 Q4	$90.4K	Buy	2,127,059 +161,572	+8%	+$6.79M	0.36%	63
2021 Q3	$85.3K	Buy	1,965,487 +1,465,651	+293%	+$64.8M	0.38%	67
2021 Q2	$21.4K	Buy	+499,836	New	+$21M	0.09%	161